The aim of the present study was to determine if serum biomarkers for neurodegeneration, serum levels of inflammatory cytokines, and biomarkers for cardiac disease (NT-proBNP) are increased in HF patients and if a combination of these biomarkers can predict cognitive performance in HF patients. The gene discussed is NPPB; the disease is hydrops fetalis.